We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock
search icon
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock

Menu

Nitroso

Nitrosamines are a group of chemical compounds that contain the nitroso functional group (NO) attached to an amine group (-NH). They can form in various ways, including through industrial processes, combustion, and certain chemical reactions, particularly involving nitrites and secondary amines. Nitrosamines are of concern because Many nitrosamines (N-Nitrosamines) are potent genotoxins; some have been classified as possible human carcinogens, although the degree of risk can vary depending on factors such as the amount of exposure and individual susceptibility. Synchemia Research Chemical is dedicated to thoroughly investigating the formation of nitroso impurities in APIs, including those related to the manufacturing processes. This approach indicates a proactive stance toward quality control and regulatory compliance. By exploring all potential sources of nitroso impurities, including those arising from the production processes themselves, Synchemia Research Chemical demonstrates a commitment to ensuring the purity, safety, and efficacy of their pharmaceutical products. Nitrosoamines, including N-Des-methyl Nitroso impurities, are important in pharmaceutical research and development due to their potential impact on drug safety and efficacy. Understanding and controlling the presence of these impurities is crucial for ensuring the quality and safety of pharmaceutical products. Can N-Nitrosamines exist in two different stable forms? N-nitrosamines substituted with two different alkyl groups can exist in two different stable forms distinguishable by several analytical methods. The two rotamers may differ in their overall dipole moment and therefore may posses different chemical and physical properties. Why do I see two peaks when analyzing N-Nitrosamines by HPLC or GC? HPLC and GC)analysis of N-nitrosamines may show two rotamers of the N-nitrosamine as two separate peaks. Whether two peaks are observed depends on the structure of the N-nitrosamine (i.e., symmetric vs. asymmetric) as well as the separation power of the analytical method.
We are the Synchemia Research Chemical specializes in manufacturing and exporting various nitrosoamine compounds, particularly focusing on N-Des-methyl Nitroso impurities of various APIs and nitroso compounds of direct APIs that contain secondary amines. By specializing in the synthesis and export of these compounds, Synchemia Research likely plays a significant role in supporting the pharmaceutical industry's efforts to meet regulatory requirements and ensure the highest standards of quality and safety in drug manufacturing.
download image Download catalogue

Pharmaceutical Reference Standards

Rivaroxaban Nitroso Impurity 6
Rivaroxaban Nitroso Impurity 6
CAT No SRC-N014566
CAS No 364745-13-1
Mol.F. C8H4N2O3
Mol.Wt. 176.1
INV STATUS CUSTOM SYNTHESIS
Rivaroxaban Nitroso Impurity 7
Rivaroxaban Nitroso Impurity 7
CAT No SRC-N014567
CAS No NA
Mol.F. C19H17ClN4O6S
Mol.Wt. 464.9
INV STATUS CUSTOM SYNTHESIS
Ledipasvir Nitroso Impurity 2
Ledipasvir Nitroso Impurity 2
CAT No SRC-N014568
CAS No NA
Mol.F. C49H52F2N10O8
Mol.Wt. 947.0
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Theophylline
N-Nitroso Theophylline
CAT No SRC-N014569
CAS No NA
Mol.F. C7H7N5O3
Mol.Wt. 209.2
INV STATUS CUSTOM SYNTHESIS
Ledipasvir Nitroso Impurity 3
Ledipasvir Nitroso Impurity 3
CAT No SRC-N014570
CAS No NA
Mol.F. C49H53F2N9O7
Mol.Wt. 918.0
INV STATUS CUSTOM SYNTHESIS
Lercanidipine Nitroso Impurity 1
Lercanidipine Nitroso Impurity 1
CAT No SRC-N014571
CAS No NA
Mol.F. C16H18N2O
Mol.Wt. 254.3
INV STATUS IN STOCK
N-Nitroso Torasemide
N-Nitroso Torasemide
CAT No SRC-N014572
CAS No NA
Mol.F. C16H19N5O4S
Mol.Wt. 377.4
INV STATUS CUSTOM SYNTHESIS
Levalbuterol Nitroso
Levalbuterol Nitroso
CAT No SRC-N014573
CAS No NA
Mol.F. C13H20N2O4
Mol.Wt. 268.3
INV STATUS CUSTOM SYNTHESIS
Levomefolate Nitroso Impurity 1
Levomefolate Nitroso Impurity 1
CAT No SRC-N014574
CAS No NA
Mol.F. C20H24N8O7
Mol.Wt. 488.5
INV STATUS CUSTOM SYNTHESIS
Levomefolate Nitroso Impurity 2
Levomefolate Nitroso Impurity 2
CAT No SRC-N014575
CAS No NA
Mol.F. C20H23N9O8
Mol.Wt. 517.5
INV STATUS CUSTOM SYNTHESIS

Let’s advance your research together.

Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.